Overexpression of antioxidant enzymes upregulates aryl hydrocarbon receptor expression via increased Sp1 DNA-binding activity

Free Radical Biology and Medicine

Volumn 49, Issue 3, 2010, Pages 487-492

  Tang, Tian ^a,b   Lin, Xinghua ^a   Yang, Hong ^a   Zhou, LiChun ^a   Wang, Zefen ^a   Shan, Guang ^a,b   Guo, ZhongMao ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Aryl hydrocarbon receptor; Catalase; Cu Zn superoxide dismutase; Endothelial cells; Specific protein 1

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; HYDROGEN PEROXIDE; MITHRAMYCIN; MITHRAMYCIN A; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; BENZO[A]PYRENE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; GENE ACTIVITY; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; REGULATORY MECHANISM; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; DRUG INACTIVATION; GENETICS; METABOLISM; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ANIMALS; BENZO(A)PYRENE; CATALASE; ENDOTHELIUM, VASCULAR; HYDROGEN PEROXIDE; INACTIVATION, METABOLIC; MICE; MICE, TRANSGENIC; PLICAMYCIN; PROMOTER REGIONS, GENETIC; RECEPTORS, ARYL HYDROCARBON; SP1 TRANSCRIPTION FACTOR; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 77954116891     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.05.007     Document Type: Article

References (21)

1. Yang H., Zhou L., Wang Z., Roberts L.J., Lin X., Zhao Y., Guo Z. Overexpression of antioxidant enzymes in ApoE-deficient mice suppresses Benzo(a)pyrene-accelerated atherosclerosis. Atherosclerosis 2009, 207:51-58.
2. Wang Z., Yang H., Ramesh A., Roberts L.J., Zhou L., Lin X., Zhao Y., Guo Z. Overexpression of Cu/Zn-superoxide dismutase and/or catalase accelerates benzo(a)pyrene detoxification by upregulation of the aryl hydrocarbon receptor in mouse endothelial cells. Free Radic. Biol. Med. 2009, 47:1221-1229.
3. Fujii-Kuriyama Y., Mimura J. Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes. Biochem. Biophys. Res. Commun. 2005, 338:311-317.
4. Nebert D.W. Drug-metabolizing enzymes in ligand-modulated transcription. Biochem. Pharmacol. 1994, 47:25-37.
5. Nebert D.W., Puga A., Vasiliou V. Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. NY Acad. Sci. 1993, 685:624-640.
6. Gelboin H.V. Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol. Rev. 1980, 60:1107-1166.
7. Mulero-Navarro S., Carvajal-Gonzalez J.M., Herranz M., Ballestar E., Fraga M.F., Ropero S., Esteller M., Fernandez-Salguero P.M. The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding. Carcinogenesis 2006, 27:1099-1104.
8. Garrison P.M., Rogers J.M., Brackney W.R., Denison M.S. Effects of histone deacetylase inhibitors on the Ah receptor gene promoter. Arch. Biochem. Biophys. 2000, 374:161-171.
9. Fitzgerald C.T., Nebert D.W., Puga A. Regulation of mouse Ah receptor (Ahr) gene basal expression by members of the Sp family of transcription factors. DNA Cell Biol. 1998, 17:811-822.
10. Yu J.H., Schwartzbauer G., Kazlman A., Menon R.K. Role of the Sp family of transcription factors in the ontogeny of growth hormone receptor gene expression. J. Biol. Chem. 1999, 274:34327-34336.
11. Li L., He S., Sun J.M., Davie J.R. Gene regulation by Sp1 and Sp3. Biochem. Cell Biol. 2004, 82:460-471.
12. Garrison P.M., Denison M.S. Analysis of the murine AhR gene promoter. J. Biochem. Mol. Toxicol. 2000, 14:1-10.
13. Fitzgerald C.T., Fernandez-Salguero P., Gonzalez F.J., Nebert D.W., Puga A. Differential regulation of mouse Ah receptor gene expression in cell lines of different tissue origins. Arch. Biochem. Biophys. 1996, 333:170-178.
14. Guo Z.M., Van Remmen H., Yang H., Chen X.L., Mele J., Vijg J., Epstein C.J., Ho Y.-S., Richardson A. Changes in expression of antioxidant enzymes affect cell-mediated LDL oxidation and oxLDL-induced apoptosis in mouse aorta cells. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1131-1138.
15. Yang H., Shi M.J., Richardson A., Vijg J., Guo Z.M. Attenuation of leukocyte-endothelium interaction by antioxidant enzymes. Free Radic. Biol. Med. 2003, 35:266-276.
16. Fletcher H.M., Schenkein H.A., Morgan R.M., Bailey K.A., Berry C.R., Macrina F.L. Virulence of a Porphyromonas gingivalis W83 mutant defective in the prtH gene. Infect. Immun. 1995, 63:1521-1528.
17. Blume S.W., Snyder R.C., Ray R., Thomas S., Koller C.A., Miller D.M. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J. Clin. Invest. 1991, 88:1613-1621.
18. Reamon-Buettner S.M., Borlak J. Epigenetic silencing of cell adhesion molecule 1 in different cancer progenitor cells of transgenic c-Myc and c-Raf mouse lung tumors. Cancer Res. 2008, 68:7587-7596.
19. Wu X., Bishopric N.H., Discher D.J., Murphy B.J., Webster K.A. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol. Cell. Biol. 1996, 16:1035-1046.
20. Ammendola R., Mesuraca M., Russo T., Cimino F. The DNA-binding efficiency of Sp1 is affected by redox changes. Eur. J. Biochem. 1994, 225:483-489.
21. Ryu H., Lee J., Zaman K., Kubilis J., Ferrante R.J., Ross B.D., Neve R., Ratan R.R. Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J. Neurosci. 2003, 23:3597-3606.